
| On the molecular determinants of the SARS-CoV-2 attack #MMPMID32311462Kanduc D; Shoenfeld YClin Immunol 2020[Jun]; 215 (?): 108426 PMID32311462show ga
?|Amino Acid Sequence[MESH]|Antibodies, Viral/chemistry/genetics[MESH]|Betacoronavirus/*immunology/pathogenicity[MESH]|COVID-19[MESH]|Coronavirus 229E, Human/immunology[MESH]|Coronavirus Infections/genetics/*immunology/pathology/virology[MESH]|Coronavirus OC43, Human/immunology[MESH]|Cross Reactions[MESH]|Epitopes/chemistry/genetics/immunology[MESH]|Gene Expression[MESH]|Host-Pathogen Interactions/genetics/immunology[MESH]|Humans[MESH]|Oligopeptides/chemistry/genetics/immunology[MESH]|Pandemics[MESH]|Pneumocystis carinii/*immunology/pathogenicity[MESH]|Pneumonia, Pneumocystis/genetics/*immunology/pathology/virology[MESH]|Pneumonia, Viral/genetics/*immunology/pathology/virology[MESH]|Protein Binding[MESH]|Pulmonary Surfactant-Associated Proteins/*chemistry/genetics/immunology[MESH]|Pulmonary Surfactants/*chemistry/immunology/metabolism[MESH]|SARS-CoV-2[MESH]|Sequence Homology, Amino Acid[MESH]
  
DeepDyve Pubget Overpricing | 
|